Lynnette Fernandez-Cuesta and Matthieu Foll were invited to present at the 6th CRCL International Cancer Symposium in Lyon (France) about the future of lung neuroendocrine tumor classification and clinical management, and how to use AI to learn simple morphological features to recognize molecular subtypes.